Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms (original) (raw)

• McNamara KM, Harwood DT, Simanainen U, Walters KA, Jimenez M, Handelsman DJ . Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol 2010; 121: 611–618.
  Article CAS PubMed Google Scholar
• Dorgan JF, Stanczyk FZ, Kahle LL, Brinton LA . Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk. Breast Cancer Res 2010; 12: R98.
  Article CAS PubMed PubMed Central Google Scholar
• Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005; 97: 755–765.
  Article CAS PubMed Google Scholar
• Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT et al. Plasma sex steroid hormones and breast cancer risk in Chinese women. Int J Cancer 2003; 105: 92–97.
  Article CAS PubMed Google Scholar
• Fourkala EO, Zaikin A, Burnell M, Gentry-Maharaj A, Ford J, Gunu R et al. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women. Endocr Relat Cancer 2012; 19: 137–147.
  Article CAS PubMed PubMed Central Google Scholar
• Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V et al. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2009; 18: 169–176.
  Article CAS PubMed Google Scholar
• Wang B, Mi M, Wang J, Wei N, Zhang Q, Zhu J et al. Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case-control study in Chongqing, China. Int J Cancer 2009; 124: 1892–1899.
  Article CAS PubMed Google Scholar
• Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005; 12: 1071–1082.
  Article CAS PubMed Google Scholar
• Zeleniuch-Jacquotte A, Shore RE, Koenig KL, Akhmedkhanov A, Afanasyeva Y, Kato I et al. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 2004; 90: 153–159.
  Article CAS PubMed PubMed Central Google Scholar
• Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE . Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004; 96: 1856–1865.
  Article CAS PubMed Google Scholar
• Key T, Appleby P, Barnes I, Reeves G, Endogenous H, . Breast Cancer Collaborative G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94: 606–616.
  Article CAS PubMed Google Scholar
• Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A et al. Serum testosterone levels and breast cancer recurrence. Int J Cancer 2005; 113: 499–502.
  Article CAS PubMed Google Scholar
• Schippinger W, Regitnig P, Dandachi N, Wernecke KD, Bauernhofer T, Samonigg H et al. Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer. Virchows Arch 2006; 449: 24–30.
  Article CAS PubMed Google Scholar
• Agrawal AK, Jelen M, Grzebieniak Z, Zukrowski P, Rudnicki J, Nienartowicz E . Androgen receptors as a prognostic and predictive factor in breast cancer. Folia Histochem Cytobiol 2008; 46: 269–276.
  Article PubMed Google Scholar
• Gonzalez LO, Corte MD, Vazquez J, Junquera S, Sanchez R, Alvarez AC et al. Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. BMC Cancer 2008; 8: 149.
  Article PubMed PubMed Central CAS Google Scholar
• Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G et al. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. Hum Pathol 2008; 39: 386–392.
  Article CAS PubMed Google Scholar
• Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH et al. Expression of androgen receptors in primary breast cancer. Ann Oncol 2010; 21: 488–492.
  Article CAS PubMed Google Scholar
• Yu Q, Niu Y, Liu N, Zhang JZ, Liu TJ, Zhang RJ et al. Expression of androgen receptor in breast cancer and its significance as a prognostic factor. Ann Oncol 2011; 22: 1288–1294.
  Article CAS PubMed Google Scholar
• Peters KM, Edwards SL, Nair SS, French JD, Bailey PJ, Salkield K et al. Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events. BMC Cancer 2012; 12: 132.
  Article CAS PubMed PubMed Central Google Scholar
• Honma N, Horii R, Iwase T, Saji S, Younes M, Ito Y et al. Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy. Breast Cancer 2013; 20: 323–330.
  Article Google Scholar
• Qu Q, Mao Y, Fei XC, Shen KW . The impact of androgen receptor expression on breast cancer survival: a retrospective study and meta-analysis. PLoS One 2013; 8: e82650.
  Article PubMed PubMed Central CAS Google Scholar
• Vera-Badillo FE, Templeton AJ, de Gouveia P, Diaz-Padilla I, Bedard PL, Al-Mubarak M et al. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 106: djt319.
  Article PubMed CAS Google Scholar
• Shufelt CL, Braunstein GD . Testosterone and the breast. Menopause Int 2008; 14: 117–122.
  Article PubMed Google Scholar
• McNamara KM, Nakamura Y, Miki Y, Sasano H . Phase two steroid metabolism and its roles in breast and prostate cancer patients. Front Endocrinol (Lausanne) 2013; 4: 116.
  Article Google Scholar
• Chen J, Wang WQ, Lin SX . Interaction of Androst-5-ene-3beta,17beta-diol and 5alpha-androstane-3beta,17beta-diol with estrogen and androgen receptors: a combined binding and cell study. J Steroid Biochem Mol Biol 2013; 137: 316–321.
  Article CAS PubMed Google Scholar
• Narayanan R, Ahn S, Cheney MD, Yepuru M, Miller DD, Steiner MS et al. Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling. PLoS One 2014; 9: e103202.
  Article PubMed PubMed Central CAS Google Scholar
• Liu YN, Liu Y, Lee HJ, Hsu YH, Chen JH . Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis. Mol Cell Biol 2008; 28: 7096–7108.
  Article CAS PubMed PubMed Central Google Scholar
• Garay JP, Karakas B, Abukhdeir AM, Cosgrove DP, Gustin JP, Higgins MJ et al. The growth response to androgen receptor signaling in ERalpha-negative human breast cells is dependent on p21 and mediated by MAPK activation. Breast Cancer Res 2012; 14: R27.
  Article CAS PubMed PubMed Central Google Scholar
• Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D'Amato NC et al. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res 2014; 16: R7.
  Article PubMed PubMed Central CAS Google Scholar
• Ni M, Chen Y, Fei T, Li D, Lim E, Liu XS et al. Amplitude modulation of androgen signaling by c-MYC. Genes Dev 2013; 27: 734–748.
  Article CAS PubMed PubMed Central Google Scholar
• Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE et al. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. J Natl Cancer Inst 1999; 91: 961–966.
  Article CAS PubMed Google Scholar
• Ni L, Llewellyn R, Kesler CT, Kelley JB, Spencer A, Snow CJ et al. Androgen induces a switch from cytoplasmic retention to nuclear import of the androgen receptor. Mol Cell Biol 2013; 33: 4766–4778.
  Article CAS PubMed PubMed Central Google Scholar
• Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005; 437: 436–439.
  Article CAS PubMed Google Scholar
• Cai C, He HH, Chen S, Coleman I, Wang H, Fang Z et al. Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell 2011; 20: 457–471.
  Article CAS PubMed PubMed Central Google Scholar
• Li Y, Wan X, Wei Y, Liu X, Lai W, Zhang L et al. LSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion. Oncol Rep 2016; 35: 3586–3592.
  Article CAS PubMed Google Scholar
• Luo H, Shenoy AK, Li X, Jin Y, Jin L, Cai Q et al. MOF acetylates the histone demethylase LSD1 to suppress epithelial-to-mesenchymal transition. Cell Rep 2016; 15: 2665–2678.
  Article CAS PubMed Google Scholar
• Ferrari-Amorotti G, Fragliasso V, Esteki R, Prudente Z, Soliera AR, Cattelani S et al. Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion. Cancer Res 2013; 73: 235–245.
  Article CAS PubMed Google Scholar
• Nam HJ, Boo K, Kim D, Han DH, Choe HK, Kim CR et al. Phosphorylation of LSD1 by PKCalpha is crucial for circadian rhythmicity and phase resetting. Mol Cell 2014; 53: 791–805.
  Article CAS PubMed Google Scholar
• Metzger E, Imhof A, Patel D, Kahl P, Hoffmeyer K, Friedrichs N et al. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. Nature 2010; 464: 792–796.
  Article CAS PubMed Google Scholar
• Remmele W, Hildebrand U, Hienz HA, Klein P-J, Vierbuchen M, Behnken LJ et al. Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Archiv A 1986; 409: 127–147.
  Article CAS Google Scholar
• Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 2010; 123: 725–731.
  Article PubMed CAS Google Scholar
• Gonzalez-Angulo AM, Stemke-Hale K, Palla SL, Carey M, Agarwal R, Meric-Berstam F et al. Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer. Clin Cancer Res 2009; 15: 2472–2478.
  Article CAS PubMed Google Scholar
• Luo X, Shi YX, Li ZM, Jiang WQ . Expression and clinical significance of androgen receptor in triple negative breast cancer. Chin J Cancer 2010; 29: 585–590.
  Article CAS PubMed Google Scholar
• Niemeier LA, Dabbs DJ, Beriwal S, Striebel JM, Bhargava R . Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod Pathol 2010; 23: 205–212.
  Article CAS PubMed Google Scholar
• Loibl S, Muller BM, von Minckwitz G, Schwabe M, Roller M, Darb-Esfahani S et al. Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat 2011; 130: 477–487.
  Article CAS PubMed Google Scholar
• Tsutsumi Y . Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Jpn J Clin Oncol 2012; 42: 375–386.
  Article PubMed Google Scholar
• Gucalp A, Tolaney S, Isakoff SJ, Ingle JN, Liu MC, Carey LA et al. Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer. Clin Cancer Res 2013; 19: 5505–5512.
  Article CAS PubMed PubMed Central Google Scholar
• Wang Y, Romigh T, He X, Tan MH, Orloff MS, Silverman RH et al. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers. Oncogene 2011; 30: 4327–4338.
  Article CAS PubMed Google Scholar
• Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P et al. The expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Iimmunohistochemical analysis in breast cancer cell lines. Breast Cancer (Auckl) 2010; 4: 35–41.
  PubMed Central Google Scholar
• Wang Y, He X, Yu Q, Eng C . Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas. Hum Mol Genet 2013; 22: 2263–2272.
  Article CAS PubMed Google Scholar
• Hickey TE, Irvine CM, Dvinge H, Tarulli GA, Hanson AR, Ryan NK et al. Expression of androgen receptor splice variants in clinical breast cancers. Oncotarget 2015; 6: 44728–44744.
  Article PubMed PubMed Central Google Scholar
• Hu DG, Hickey TE, Irvine C, Wijayakumara DD, Lu L, Tilley WD et al. Identification of androgen receptor splice variant transcripts in breast cancer cell lines and human tissues. Horm Cancer 2014; 5: 61–71.
  Article CAS PubMed Google Scholar
• Peters AA, Buchanan G, Ricciardelli C, Bianco-Miotto T, Centenera MM, Harris JM et al. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Res 2009; 69: 6131–6140.
  Article CAS PubMed Google Scholar
• Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L, Arisio R et al. Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers. Breast Cancer Res Treat 2010; 124: 607–617.
  Article CAS PubMed Google Scholar
• Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ, Cole K et al. Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res 2011; 17: 1867–1874.
  Article CAS PubMed PubMed Central Google Scholar
• Witzel I, Graeser M, Karn T, Schmidt M, Wirtz R, Schutze D et al. Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers. J Cancer Res Clin Oncol 2013; 139: 809–816.
  Article CAS PubMed Google Scholar
• Micello D, Marando A, Sahnane N, Riva C, Capella C, Sessa F . Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers. Virchows Arch 2010; 457: 467–476.
  Article CAS PubMed Google Scholar
• Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS et al. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Ann Oncol 2011; 22: 1755–1762.
  Article CAS PubMed Google Scholar
• Abdulla A, Zhang Y, Hsu FN, Xiaoli AM, Zhao X, Yang ES et al. Regulation of lipogenic gene expression by lysine-specific histone demethylase-1 (LSD1). J Biol Chem 2014; 289: 29937–29947.
  Article CAS PubMed PubMed Central Google Scholar
• Ni M, Chen Y, Lim E, Wimberly H, Bailey ST, Imai Y et al. Targeting androgen receptor in estrogen receptor-negative breast cancer. Cancer Cell 2011; 20: 119–131.
  Article CAS PubMed PubMed Central Google Scholar
• Robinson JL, Macarthur S, Ross-Innes CS, Tilley WD, Neal DE, Mills IG et al. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J 2011; 30: 3019–3027.
  Article CAS PubMed PubMed Central Google Scholar
• Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011; 121: 2750–2767.
  Article CAS PubMed PubMed Central Google Scholar
• McNamara KM, Yoda T, Takagi K, Miki Y, Suzuki T, Sasano H . Androgen receptor in triple negative breast cancer. J Steroid Biochem Mol Biol 2013; 133: 66–76.
  Article CAS PubMed Google Scholar
• He J, Peng R, Yuan Z, Wang S, Peng J, Lin G et al. Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray. Med Oncol 2012; 29: 406–410.
  Article CAS PubMed Google Scholar
• Tang D, Xu S, Zhang Q, Zhao W . The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer. Med Oncol 2012; 29: 526–533.
  Article CAS PubMed Google Scholar
• Mrklic I, Pogorelic Z, Capkun V, Tomic S . Expression of androgen receptors in triple negative breast carcinomas. Acta Histochem 2013; 115: 344–348.
  Article CAS PubMed Google Scholar
• Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO . Prognostic markers in triple-negative breast cancer. Cancer 2007; 109: 25–32.
  Article CAS PubMed Google Scholar
• Harwood DT, Handelsman DJ . Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin Chim Acta 2009; 409: 78–84.
  Article CAS PubMed Google Scholar
• Rothman MS, Carlson NE, Xu M, Wang C, Swerdloff R, Lee P et al. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. Steroids 2011; 76: 177–182.
  Article CAS PubMed Google Scholar
• Bui HN, Sluss PM, Blincko S, Knol DL, Blankenstein MA, Heijboer AC . Dynamics of serum testosterone during the menstrual cycle evaluated by daily measurements with an ID-LC-MS/MS method and a 2nd generation automated immunoassay. Steroids 2013; 78: 96–101.
  Article CAS PubMed Google Scholar
• Amente S, Lania L, Majello B . The histone LSD1 demethylase in stemness and cancer transcription programs. Biochim Biophys Acta 2013; 1829: 981–986.
  Article CAS PubMed Google Scholar
• Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119: 941–953.
  Article CAS PubMed Google Scholar
• Wissmann M, Yin N, Muller JM, Greschik H, Fodor BD, Jenuwein T et al. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat Cell Biol 2007; 9: 347–353.
  Article CAS PubMed Google Scholar
• Perillo B, Ombra MN, Bertoni A, Cuozzo C, Sacchetti S, Sasso A et al. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 2008; 319: 202–206.
  Article CAS PubMed Google Scholar
• Garcia-Bassets I, Kwon YS, Telese F, Prefontaine GG, Hutt KR, Cheng CS et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007; 128: 505–518.
  Article CAS PubMed PubMed Central Google Scholar
• Nair SS, Nair BC, Cortez V, Chakravarty D, Metzger E, Schule R et al. PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity. EMBO Rep 2010; 11: 438–444.
  Article CAS PubMed PubMed Central Google Scholar
• Amente S, Bertoni A, Morano A, Lania L, Avvedimento EV, Majello B . LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription. Oncogene 2010; 29: 3691–3702.
  Article CAS PubMed Google Scholar
• Amente S, Lania L, Avvedimento EV, Majello B . DNA oxidation drives Myc mediated transcription. Cell Cycle 2010; 9: 3002–3004.
  Article CAS PubMed Google Scholar
• Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, Wassell R et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 2002; 10: 1119–1128.
  Article CAS PubMed Google Scholar
• Biswas D, Milne TA, Basrur V, Kim J, Elenitoba-Johnson KS, Allis CD et al. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes. Proc Natl Acad Sci USA 2011; 108: 15751–15756.
  Article CAS PubMed PubMed Central Google Scholar
• Huang PH, Chen CH, Chou CC, Sargeant AM, Kulp SK, Teng CM et al. Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases. Mol Pharmacol 2011; 79: 197–206.
  Article CAS PubMed PubMed Central Google Scholar
• Feng J, Xu G, Liu J, Zhang N, Li L, Ji J et al. Phosphorylation of LSD1 at Ser112 is crucial for its function in induction of EMT and metastasis in breast cancer. Breast Cancer Res Treat 2016; 159: 443–456.
  Article CAS PubMed Google Scholar
• Verrijdt G, Haelens A, Claessens F . Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression. Mol Genet Metab 2003; 78: 175–185.
  Article CAS PubMed Google Scholar
• Nelson JD, Denisenko O, Bomsztyk K . Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc 2006; 1: 179–185.
  Article CAS PubMed Google Scholar
• Harmeyer KM, South PF, Bishop B, Ogas J, Briggs SD . Immediate chromatin immunoprecipitation and on-bead quantitative PCR analysis: a versatile and rapid ChIP procedure. Nucleic Acids Res 2015; 43: e38.
  Article PubMed CAS Google Scholar
• Kocatürk B, Versteeg HH . Orthotopic injection of breast cancer cells into the mammary fat pad of mice to study tumor growth. J Vis Exp 2015; e-pub ahead of print 8 February 2015doi:10.3791/51967.